Racca S - Search Results

1

Opposite effects of dehydroepiandrosterone on the growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas.

Boccuzzi G, Aragno M, Brignardello E, Tamagno E, Conti G, Di Monaco M, Racca S, Danni O, Di Carlo F. Boccuzzi G, et al. Among authors: racca s. Anticancer Res. 1992 Sep-Oct;12(5):1479-83. Anticancer Res. 1992. PMID: 1444210

2

Potentiation of medroxyprogesterone acetate antineoplastic activity by histidine in rat mammary tumours.

Di Carlo F, Conti G, Giubertoni M, Muccioli G, Racca S. Di Carlo F, et al. Among authors: racca s. Cancer Chemother Pharmacol. 1991;27(4):271-7. doi: 10.1007/BF00685111. Cancer Chemother Pharmacol. 1991. PMID: 1825621

3

Growth inhibition of DMBA-induced rat mammary carcinomas by UK 114.

Racca S, Di Carlo F, Bartorelli A, Bussolati B, Bussolati G. Racca S, et al. Virchows Arch. 1997 Nov;431(5):323-8. doi: 10.1007/s004280050106. Virchows Arch. 1997. PMID: 9463573

4

The aspirin metabolite, salicylate, inhibits 7,12-dimethylbenz[a]anthracene-DNA adduct formation in breast cancer cells.

Abbadessa G, Spaccamiglio A, Sartori ML, Nebbia C, Dacasto M, Di Carlo F, Racca S. Abbadessa G, et al. Among authors: racca s. Int J Oncol. 2006 May;28(5):1131-40. Int J Oncol. 2006. PMID: 16596229

5

Correlations among receptor status, estrogen receptor (ER) form (8S and/or 4S) and labelling index (LI) in human breast cancer.

Badino P, Conti G, Giubertoni M, Racca S, Di Carlo F. Badino P, et al. Among authors: racca s. Pharmacol Res. 1990 Sep-Oct;22 Suppl 3:5-6. doi: 10.1016/1043-6618(90)90558-u. Pharmacol Res. 1990. PMID: 2097642 No abstract available.

6

Histidine increases estrogen and progesterone receptor levels in rat mammary tumors.

Racca S, Badino P, Carozzi S, Conti G, Giubertoni M, Squillario P, Di Carlo F. Racca S, et al. Pharmacol Res. 1990 Sep-Oct;22 Suppl 3:13-4. doi: 10.1016/s1043-6618(09)80006-6. Pharmacol Res. 1990. PMID: 2129062 No abstract available.

7

Histidine potentiates the antiproliferative effect of medroxyprogesterone acetate (MPA) on a human breast cancer cell line.

Giubertoni M, Badino P, Conti G, Racca S, Di Carlo F. Giubertoni M, et al. Among authors: racca s. Pharmacol Res. 1990 Sep-Oct;22 Suppl 3:9-10. doi: 10.1016/s1043-6618(09)80004-2. Pharmacol Res. 1990. PMID: 2151472 No abstract available.

8

Effects of medroxyprogesterone acetate (MPA) on phosphodiesterase (PDE) activity in DMBA-induced rat mammary tumours.

Racca S, Squillario P, Carozzi S, Bedino S, Testore G, Giubertoni M, Di Carlo F. Racca S, et al. Pharmacol Res. 1989 Jan-Feb;21(1):101-2. doi: 10.1016/1043-6618(89)90133-3. Pharmacol Res. 1989. PMID: 2542917 No abstract available.

9

High tumour prolactin receptor content and lack of increase in serum prolactin levels as predictors of good response to endocrine therapy in rat mammary cancer.

Di Carlo F, Muccioli G, Bellussi G, Conti G, Racca S. Di Carlo F, et al. Among authors: racca s. Int J Cancer. 1988 May 15;41(5):767-70. doi: 10.1002/ijc.2910410522. Int J Cancer. 1988. PMID: 2966772

10

Effects of medroxyprogesterone acetate on serum prolactin levels and liver prolactin binding capacity in the rat.

Muccioli G, Racca S, Ricci Gamalero S, Di Carlo F. Muccioli G, et al. Among authors: racca s. Pharmacol Res Commun. 1988 Aug;20(8):719-30. doi: 10.1016/s0031-6989(88)80119-x. Pharmacol Res Commun. 1988. PMID: 3212009

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters